HHS in Biological Technology

PharmAthene to Present Data for Protexia(R) and Valortim(R) at HHS PHEMCE Stakeholders Workshop 2008

ANNAPOLIS, Md., Sept. 18 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (Amex: PIP ), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company will present two poster presentations and an oral presentation on its Protexia(R...

Bavarian Nordic Receives $50 Million Advance Payment from HHS for Fulfilling Contract Milestones

WASHINGTON, D.C., October 9 /PRNewswire-FirstCall/ -- Bavarian Nordic, the Danish-based international biopharmaceutical company, has received permission from the Department of Health and Human Services (HHS) to invoice an advance payment of $50 million as allowed under the recent contract (RFP...

WTN Interview: HHS Secretary calls for $550 million health care fund to reduce deaths caused by medical errors

Dont forget Wisconsin Thompson tells BIO attendees Editors note : SAN FRANCISCO Wisconsins consummate cheerleader, former governor and current Secretary of Health and Human Services Tommy Thompson, was the featured lunch keynote speaker Monday at the BIO 2004 Conference, talking place thi...

Federal advisor to HHS describes the national information infrastructure

MADISON In a speech given April 27, President Bush proclaimed that health care in America is in desperate need of aid, citing a 21st century health care system [which] uses a 19th century paperwork system. While this seems to be a grim statement, Dr. William Yasnoff , a physician and computer sci...

Thompson's HHS legacy will include efforts to combat disease in Africa

Pictured: Dan Vogel, Department of Health and Human Services; Tom Still, Wisconsin Technology Council; Tommy G. Thompson, Department of Health and Human Services and park warden at Arusha National Park near Mt. Kilimanjaro in Tanzania Arusha, Tanzania Even if former Wisconsin Gov. Tommy Tho...

Federal Health Architecture: An Interview with Kathleen Heuer, HHS

Editors note: Kathleen Heuer, Deputy Asst. Sec. Budget, Technology and Finance U.S. Dept. of Health and Human Services, will discuss the Federal Health Architecture at the upcoming Digital Healthcare Conference being held June 23 , in Madison, Wis. The FHA is a methodology for developing health...

PharmAthene, Inc. Closes on $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants

...f U.S. government funding for one or more of the Company's development programs, including without limitation our bid related to SparVax(TM) under the hhs Request for Proposals for an Anthrax Recombinant Protective Antigen (rPA) Vaccine for the Strategic National Stockpile, the award of government contra...

PharmAthene's 2nd Generation rPA Anthrax Vaccine, SparVax(TM), Completes FDA Regulatory Strategy Review

... licensure, for SparVax(TM). In amending the RFP, hhs required that all bidders in the competitive range...to the development program previously submitted to hhs as part of our proposal in response to the RFP, an...imitation our bid related to SparVax(TM) under the hhs Request for Proposals for an Anthrax Recombinant P...

HHS Awards MedImmune Contract to Manufacture Live Attenuated Nasal Spray Vaccine for Novel Influenza A (H1N1)

... manufacture monovalent (single-strain) live attenuated influenza vaccine for Novel Influenza A (H1N1) to vaccinate priority populations identified by hhs in the National Strategy for Pandemic Influenza. An initial order of $90 million of vaccine has been placed, with the potential for additional orders...

XIFIN Inc. CEO to Speak at Executive War College Conference

...CD to include diagnostic and operative procedures, which is used for health records, reimbursement systems, and public data. On August 21st, 2008, the hhs proposed new code sets to be used for reporting diagnoses on health care transactions. Under the proposal, the ICD-9-CM code sets would be replaced wi...

BioCryst Reports Fourth Quarter and Year End 2008 Financial Results and Provides Corporate Update

...n by a reduction in revenue from the contract with hhs for the development of peramivir, plus a $4.9 mill... that were previously expected to be received from hhs related to costs incurred in the Phase 3 program o...equate dosing by intramuscular injection for which hhs or the Food & Drug Administration (FDA) may no...

Seasonal Influenza Activity Increasing Across Europe - H3N2 Dominant Strain

... drug resistance in multiple distinct lineages of H5N1 avian influenza. Infections, Genetics and Evolution. 2008 (4) 'Cost, resistance aired in hhs webcast on antivirals'. CIDRAP News. December 17 2008 http://www.cidrap.umn.edu/cidrap/content/influenza/panflu/news/dec1708webinar . html Accessed 1...

BioCryst to Present at the J.P. Morgan 27th Annual Healthcare Conference

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

BioCryst to Present Three Posters During the 50th American Society of Hematology Annual Meeting and Exposition

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

BioCryst Reports Third Quarter 2008 Financial Results and Provides Corporate Update

...ounts BioCryst previously expected to receive from hhs related to costs incurred in the Phase 3 program i...mivir program through Phase 2 clinical trials from hhs and a strong cash position that will allow us to e...y intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not a...

BioCryst Reports Results From the First-Ever Completed Active-Controlled Phase 2 Study in Hospitalized Influenza

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

BioCryst Pharmaceuticals To Announce Third Quarter 2008 Financial Results On October 31, 2008

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

Peramivir Phase 2 Data for the Treatment of Outpatient Influenza to be Presented at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

BioCryst to Present at the JMP Healthcare Focus Conference

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

AHIC Successor, Inc. Announces Board of Directors

...lto Medical Foundation In addition to the new Board members listed above, hhs Secretary Mike Leavitt and Veterans Affairs Secretary James Peake will serv...t AHIC, which is scheduled to complete its work by the end of 2008, advises hhs on how to accelerate the development and adoption of health information tec...

BioCryst to Present at UBS 2008 Global Life Sciences Conference

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

GlaxoSmithKline Offers New Purchasing Options to Help Employers Overcome Barriers to Pandemic Stockpiling of Relenza(R)

... and to stockpile the antivirals they will need to protect their employees. hhs acknowledges the importance of diversifying stockpiles and recommends the s...eservation option would be able to purchase their reserved RELENZA units. hhs has developed pandemicflu.gov to be a resource for all of these entities wh...

BioCryst Pharmaceuticals To Announce Second Quarter 2008 Financial Results on August 7, 2008

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

Roche Introduces Program to Facilitate Corporate Pandemic Stockpiling of Tamiflu(R)

... noted that the private sector "should play an integral role in preparedness before a pandemic begins, and should be part of the national response." hhs took it a step further on the department's pandemic preparedness web site, http://www.pandemicflu.gov, indicating that: "In the event of pandemic in...

William P. Sheridan Appointed Chief Medical Officer of BioCryst Pharmaceuticals

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

BioCryst Reports First Quarter 2008 Financial Results and Clinical Update

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile

...produce approximately 38.5 million doses of vaccine to protect against a new strain of avian influenza. Sanofi Pasteur has a multi- year contract with hhs as part of its pandemic program, and will receive a payment of $192.5 million booked in the second quarter of 2008 for acceptance of the bulk vaccine ...

Oregon Health Care Quality Corporation Receives Important Designation from U.S. Department of Health and Human Services

...Care Quality Corporation (Quality Corp) is receiving the Chartered Value Exchange designation from the U.S. Department of Health and Human Services. hhs is recognizing 14 community-based organizations around the country as the first Chartered Value Exchanges, and Secretary Leavitt will personally recog...

BioCryst Reports Fourth Quarter and Year End 2007 Financial Results and Corporate Update

...is primarily due to revenue from the contract with hhs for the development of peramivir, a $7 million mil...osure in subjects. BioCryst continues to work with hhs to further advance the peramivir program. ...y intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not a...

BioCryst Pharmaceuticals to Announce Fourth Quarter and Fiscal Year 2007 Financial Results on March 4, 2008

...receive adequate dosing by intramuscular injection may not be correct, that hhs and the Food & Drug Administration (FDA) may not agree with our analysis, that hhs may further condition, reduce or eliminate future funding of the peramivir ...

Dr. Charles A. Sims of California Cryobank's Family Cord Blood Services Named to National Stem Cell Advisory Council

... matters of public policy, regulation and the development of industry standards by accrediting organizations. Established to advise the Secretary of hhs and Administrator of HRSA on activities of the C.W. Bill Young Cell Transplantation Program and the National Cord Blood Inventory (NCBI) Program, the ...

Department of Health & Human Services Names Dr. Eric Rose to National Biodefense Science Board

...fficer of SIGA Technologies, Inc., has been named to the National Biodefense Science Board (NBSB). The NBSB will provide expert advice and guidance to hhs Secretary Mike Leavitt on scientific, technical and other matters of special interest to the Department regarding activities to prevent, prepare for a...

VaxGen Addresses MPM Claims in Letter to Stockholders

...nce again ill-defined, and the stated requirements and contract performance period would indicate that no deliveries are expected this decade. Lastly, hhs is under no obligation to proceed with a procurement having issued a draft RFP. Perhaps this RFP will spur interest in the program. However, we have n...

HHS Secretary Leavitt Announces Members of the National Biodefense Science Board

... WASHINGTON, Dec. 17 /PRNewswire-USNewswire/ -- hhs Secretary Mike Leavitt today announced the members of the National Biodefen...f 49 scientific articles and currently holds 21 U.S. patents. Note: All hhs press releases, fact sheets and other press materials are available at htt...

So Long, Old Friend: The End of the Blockbuster Drug Era? What 2008 Holds for Bringing Drugs to Market

... Hoffmann-La Roche Inc. CEO George Abercrombie, Pfizer R&D Head Martin Mackay, hhs Deputy Secretary Tevi Troy, Former CMS Administrator & FDA Commissioner Mark McClellan Headline Agenda at FDA/CMS Summit 2007 WASHINGTON, Nov. 15 /P...

MHA Announces: Tommy Thompson to be Keynote Speaker at The MHA 5th Annual Business Summit

...mplement a new Medicare law (Medicare Part D) that for the first time provided a drug benefit to America's seniors. Building on his esteemed career as hhs Secretary and Governor, Secretary Thompson continues to develop innovative solutions to the health care challenges facing American families, businesse...

Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market

...Site(R) technology designed to provide controlled release of peptide and protein-based drugs. The GelVac(TM) formulation of GelSite is being funded by hhs and is being developed as a nasal powder delivery system for vaccines and therapeutics in particular the H5N1 Avian (Bird) Flu. Research on Carrington...

HHS Issues First Department-Wide Report on Personalized Health Care

...urance. Some highlights of related activities in hhs include: -- Genome-wide Association Studies, spo...cal practice. The report is available on the hhs Web site at http://www.hhs.gov/myhealthcare/ . Note: All hhs press releases, fact sheets and other press materi...

HHS Clarifies Research Use of Data

...ng to a letter from Stan Crosley, chief privacy officer of Indianapolis-based Eli Lilly. In a response letter, Richard Campanelli, director of the hhs Office of Civil Rights, wrote, "We wish to emphasize that the privacy rule does not require IRBs to review HIPAA authorizations for compliance with th...

Wisconsin to Receive $25 Million for Bioterrorism

...for labs, technology, research, communication and planning WASHINGTON - hhs Secretary Tommy G. Thompson today announced that the Department of Health a...n, education and training and smallpox preparedness planning. This year, hhs is spending $3.5 billion this year for bioterrorism preparedness, including...